|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/18 | (2006.01) |
| C07K 14/475 | (2006.01) |
| (11) | Number of the document | 2964250 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14713728.5 |
| Date of filing the European patent application | 2014-03-07 | |
| (97) | Date of publication of the European application | 2016-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-16 |
| (46) | Date of publication of the claims translation | 2018-07-25 |
| (86) | Number | PCT/US2014/022102 |
| Date | 2014-03-07 |
| (87) | Number | WO 2014/138687 |
| Date | 2014-09-12 |
| (30) | Number | Date | Country code |
| 201361775400 P | 2013-03-08 | US | |
| 201461938123 P | 2014-02-10 | US |
| (72) |
JOHNSON, Kristen, US
SHI, Jian, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Peptidai ir kompozicijos, skirti sąnarių pažeidimų gydymui |
| PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 13 | 289.00 EUR |
| 2027-03-07 |